Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study
- PMID: 28964260
- PMCID: PMC5622554
- DOI: 10.1186/s12931-017-0659-x
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study
Abstract
Background: Bronchiectasis (BE) is a chronic structural lung disease with frequent exacerbations, some of which require hospital admission though no clear associated factors have been identified. We aimed to evaluate factors associated with hospitalization due to exacerbations during a 1-year follow-up period.
Methods: A prospective observational study was performed in patients recruited from specialized BE clinics. We considered all exacerbations diagnosed and treated with antibiotics during a follow-up period of 1 year. The protocol recorded baseline variables, usual treatments, Bronchiectasis Severity Index (BSI) and FACED scores, comorbid conditions and prior hospitalizations.
Results: Two hundred and 65 patients were recruited, of whom 162 required hospital admission during the follow-up period. Independent risk factors for hospital admission were age, previous hospitalization due to BE, use of proton pump inhibitors, heart failure, FACED and BSI, whereas pneumococcal vaccination was a protective factor. The area under the receiver operator characteristic curve (AUC) was 0.799 for BSI model was 0.799, and 0.813 for FACED model.
Conclusions: Previous hospitalization, use of proton pump inhibitors, heart failure along with BSI or FACED scores is associated factors for developing exacerbations that require hospitalization. Pneumococcal vaccination was protective. This information may be useful for the design of preventive strategies and more intensive follow-up plans.
Conflict of interest statement
Ethics approval and consent to participate
Comité Ético de Investigación Clínica CEIC Hospital La Fe (2011/0140).
Consent for publication
All authors have accepted the publication of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Performance of Multidimensional Severity Scoring Systems in Patients with Post-Tuberculosis Bronchiectasis.Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2157-2165. doi: 10.2147/COPD.S261797. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32982208 Free PMC article.
-
Prognostic utility of various multidimensional grading scales among Saudi patients with bronchiectasis.Respir Med Res. 2021 Nov;80:100843. doi: 10.1016/j.resmer.2021.100843. Epub 2021 Jun 7. Respir Med Res. 2021. PMID: 34174526
-
The bronchiectasis severity index. An international derivation and validation study.Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85. doi: 10.1164/rccm.201309-1575OC. Am J Respir Crit Care Med. 2014. PMID: 24328736 Free PMC article.
-
Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity.Arch Bronconeumol (Engl Ed). 2019 Feb;55(2):81-87. doi: 10.1016/j.arbres.2018.07.002. Epub 2018 Aug 16. Arch Bronconeumol (Engl Ed). 2019. PMID: 30119935 English, Spanish.
-
Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.Biosci Rep. 2020 Oct 30;40(10):BSR20194514. doi: 10.1042/BSR20194514. Biosci Rep. 2020. PMID: 33057706 Free PMC article.
Cited by
-
Pulmonary exacerbations in insured patients with bronchiectasis over 2 years.ERJ Open Res. 2023 Jul 3;9(4):00021-2023. doi: 10.1183/23120541.00021-2023. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37404848 Free PMC article.
-
Performance of Multidimensional Severity Scoring Systems in Patients with Post-Tuberculosis Bronchiectasis.Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2157-2165. doi: 10.2147/COPD.S261797. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32982208 Free PMC article.
-
The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis.ERJ Open Res. 2024 Sep 30;10(5):01032-2023. doi: 10.1183/23120541.01032-2023. eCollection 2024 Sep. ERJ Open Res. 2024. PMID: 39351390 Free PMC article.
-
Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan.Front Med (Lausanne). 2022 Jan 21;8:812775. doi: 10.3389/fmed.2021.812775. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35127767 Free PMC article.
-
COPD Assessment Test and risk of readmission in patients with bronchiectasis: a prospective cohort study.ERJ Open Res. 2024 Mar 18;10(2):00867-2023. doi: 10.1183/23120541.00867-2023. eCollection 2024 Mar. ERJ Open Res. 2024. PMID: 38500792 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources